This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

5 alpha-reductase

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

5 alpha-reductase is an enzyme that is present in highest concentration in the male reproductive tissues, the skin, especially that overlying the genitalia, and the liver. It converts testosterone to dihydrotestosterone, which has a greater affinity for androgen receptors than testosterone, and thus enhances the androgen action of testosterone.

Two isoenzymes of 5 alpha-reductase enzyme are recognised (1):

  • type 1 - which is located on the short arm of chromosome 7 and occurs in all skin tissues
  • type 2 - which is located on the short arm of chromosome 2 and occurs mainly in the genital skin

In 5 alpha-reductase deficiency, the type 2 isoenzyme is that which is lacking. Men with this condition do not develop male-pattern baldness despite evidence that the type 1 isoenzyme is the dominant form in the adult male scalp, and in 5 alpha-reductase deficiency, this isoenzyme is present at normal levels. Thus, one must conclude that the type 2 isoenzyme is necessary to the development of male pattern baldness (1,2).

Reference:

  • Andersson, S. et al. (1991), Deletion of steroid 5 alpha-reductase 2 gene in male pseudohermaphroditism, Nature, 354, 159-61.
  • Rittmaster RS (1994). Finasteride. NEJM, 330, 121-6.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.